Our professionals
Dr. Rafael Valdés Mas
Principal Investigator of the Microbiome and Clinical Physiology Group.
Preferential dedication: understanding host-microbiota-diet interactions to develop targeted therapies that prevent and treat human diseases and promote healthy aging.
Be part of:
Cima Universidad de Navarra
INDEX H
28
Professional career
- Postdoctoral researcher (Weizmann Institute, Elinav lab, 2024)
- Chief Scientific Officer (CSO) and Bioinformatic scientist (DREAMgenics, 2020)
- Ph.D. Biomedicine and Molecular Oncology (University of Oviedo, 2016)
- Master’s in Biomedicine and Molecular Oncology (University of Oviedo, 2012)
- Industrial Engineering, Specialization in Electronics (University of Oviedo, 2011)
RESEARCH AREAS
His research focuses on understanding how host, microbiome, and diet interactions influence disease development, particularly cancer, and human aging. He uses multi-omics approaches and advanced computational methodologies to explore microbiome interactions with human biological processes, validating them through advanced in-vitro experiments, such as organoids, and animal disease models. The ultimate goal is to translate these laboratory findings into clinical applications through human studies.
AREAS OF INTEREST
- Develop novel computational approaches to integrate multi-omics data and characterize the complex interactions between the host, microbiome, and diet.
- Uncover microbiome-driven mechanisms influencing human diseases and aging processes.
- Design microbiome- and diet-based targeted therapies for disease prevention and treatment.
Activity
As a researcher
Co-author of more than 40 scientific articles in journals such as Nature, Cell, and Science.Author of 3 patents.
More information
Latest scientific publications
- Metagenome-informed metaproteomics of the human gut microbiome, host, and dietary exposome uncovers signatures of health and inflammatory bowel disease Jan 20, 2025 | Magazine: Cell
- Phage therapy in noncommunicable diseases Oct 20, 2023 | Magazine: Science